Publication Number
WO/2024/118029
Publication Date
06.06.2024
International Application No.
PCT/TR2023/051354
International Filing Date
20.11.2023
Title
[English]
A PHARMACEUTICAL FORMULATION COMPRISING EMPAGLIFLOZIN
[French]
FORMULATION PHARMACEUTIQUE COMPRENANT DE L'EMPAGLIFLOZINE
Applicants **
SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI
Istınye Mahallesı Balabandere Caddesı No:14
34460 Sarıyer/Istanbul, TR
Inventors **
SUNEL, Fatih
Istınye Mahallesı Balabandere Caddesı No:14
34460 Sarıyer/Istanbul, TR
PEHLIVAN AKALIN, Nur
Istınye Mahallesı Balabandere Caddesı No:14
34460 Sarıyer/Istanbul, TR
ARMUT, Merve
Istınye Mahallesı Balabandere Caddesı No:14
34460 Sarıyer/Istanbul, TR
Priority Data
2022/018110
29.11.2022
TR
Application details
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Abstract
[English]
The present invention relates to a pharmaceutical formulation comprising Empagliflozin or a pharmaceutically acceptable salt thereof wherein Empagliflozin or pharmaceutically acceptable salt has a d (0.9) particle size between 1 and 5 µm. The present invention also relates to a simple, rapid, cost effective, time-saving and industrially convenient method of preparing the formulation.
[French]
La présente invention concerne une formulation pharmaceutique comprenant de l'empagliflozine ou un sel pharmaceutiquement acceptable de celle-ci, l'empagliflozine ou un sel pharmaceutiquement acceptable ayant une taille de particule d (0,9) comprise entre 1 et 5 µm. La présente invention concerne également un procédé simple, rapide, économique, économe en temps et industriellement pratique de préparation de la formulation.